Is angelinipharma.de Safe? Security Analysis for Angelini Pharma Deutschland GmbH
https://angelinipharma.deCheck if angelinipharma.de is a scam or legitimate. Free security scan and reviews.
Below Healthcare avg (65)
10,000+
Domains scanned
500+
Security teams trust us
EveryPay
Secure checkout
Instant
Reports delivered
Get the professional PDF report for angelinipharma.de
Export this security analysis as a professional PDF document, receive it via email, and access marketing intelligence data including contact emails and phone numbers. One-time purchase for lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
AI Summary
Angelini Pharma Deutschland GmbH is the German subsidiary of the international pharmaceutical division of the private Italian Angelini Group. Established in Germany since 2020, the company focuses on therapeutic areas including Consumer Health and Brain Health, aiming to alleviate neurological disorders and protect mental health. The website presents a professional and consistent brand image, targeting patients, healthcare professionals, and consumers interested in pharmaceutical products. The company operates internationally with multiple subsidiaries across Europe and the USA, reflecting a medium-sized enterprise with a strong market presence. Technically, the website employs modern JavaScript libraries such as jQuery, Slick Carousel, and Magnific Popup, alongside Piwik PRO for analytics, indicating a mature digital infrastructure. The site is mobile-optimized with good SEO and accessibility basics, though no explicit CMS or hosting provider is identified. Performance is moderate, with asynchronous loading of scripts and preconnect hints enhancing speed. From a security perspective, the site enforces HTTPS and uses analytics with anonymization options, but lacks explicit security headers like Content-Security-Policy or X-Frame-Options. No vulnerabilities or exposed sensitive data were detected in the HTML content. Privacy and cookie policies are present and GDPR compliant, with clear contact information provided. However, no dedicated security policy or incident response contacts were found, and no vulnerability disclosure mechanism is published. Overall, the website is trustworthy, professionally maintained, and compliant with privacy regulations. Strategic improvements include enhancing security headers, publishing a security policy, and establishing a vulnerability disclosure process to strengthen security posture and stakeholder trust.
Detected Technologies
9 urgent findings need attention
1 critical · 8 high
- + 1 more findings in the full report below
Keep angelinipharma.de under constant watch
Guard tracks your live infrastructure daily: certificate expiry, DNS & mail authentication drift, uptime changes, subdomain inventory, and unexpected tracker or content shifts. A full timeline captures every diff so you can prove remediation and spot regressions instantly.
Security drift alerts
Risk score drops, new high-severity issues, and header hardening gaps
Compliance watch
GDPR / NIS2 posture changes with governance evidence snapshots
Infrastructure surface
Unexpected open services, SSL expiry, DNS & email authentication changes
Content & tracker intelligence
Marketing tech shifts, analytics drift, and AI recommendation updates
Cancel anytime. Alerts sent to the contacts you choose. Unlock the full report to view historical timelines and alerts.
Security Headers
2 findings
90/100
GDPR Compliance
3 findings
68/100
NIS2 Compliance
9 findings
2/100
Email Security
3 findings
45/100
🧠AI Business Intelligence
Technology stack, business insights, and market analysis powered by AI.
Business Intelligence
Market & Strategic Analysis
Angelini Pharma Deutschland GmbH holds a solid position as a pharmaceutical company specializing in brain health and consumer health products within the German and broader European markets. As part of the Angelini Group, it benefits from a broad international footprint with subsidiaries in multiple countries, enabling diversified market access and product portfolios. The business model centers on pharmaceutical research, development, and production, targeting patients and healthcare providers. The company leverages strategic partnerships and maintains a strong brand presence, supported by certifications such as Top Employer awards. Growth indicators include recent establishment in Germany (2020) and active communication of corporate responsibility and innovation projects. The partnership ecosystem includes related Angelini Pharma sites and specialized health platforms, enhancing market reach and credibility.
Extracted Contact Information
Marketing Intelligence Data
Physical Addresses (1)
Company Registration
Angelini Pharma Deutschland GmbH
HRB 254897
Security Posture Analysis
Comprehensive Security Assessment
The current security maturity level of the website is moderate. HTTPS is enforced, ensuring encrypted communications. The use of Piwik PRO analytics with anonymization options reflects attention to privacy compliance. However, the absence of key security headers such as Content-Security-Policy, X-Frame-Options, and X-Content-Type-Options represents a gap that could expose the site to clickjacking, MIME sniffing, or content injection attacks. No incident response or security contact information is provided, limiting transparency and readiness for security events. No vulnerability disclosure policy or security.txt file is present, which is a best practice for responsible vulnerability management. The site does not expose sensitive data or use vulnerable libraries visibly, but third-party scripts require ongoing monitoring. Overall, the security posture is adequate but could be improved with enhanced headers and formal security policies.
Strategic Recommendations
Priority Actions for Security Improvement
Implement comprehensive security headers including Content-Security-Policy, X-Frame-Options, X-Content-Type-Options, and Referrer-Policy to mitigate common web vulnerabilities.
✨Observations
AI-powered comprehensive website and business analysis.
AI-Enhanced Website Analysis
Business Insights
Angelini Pharma Deutschland GmbH
Angelini Pharma ist die internationale Pharmasparte der privaten italienischen Angelini Group. Seit 2020 ist Angelini Pharma auch mit einer Tochtergesellschaft in Deutschland vertreten. Angelini Pharma engagiert sich für Patient:innen in den therapeutischen Bereichen Consumer Health und Brain Health und arbeitet täglich daran, neurologische Störungen zu lindern und gleichzeitig die mentale Gesundheit zu schützen.
good
consistent
Technical Stack
moderate
good
basic
good
Security Assessment
- HTTPS enforced
- No exposed sensitive data in HTML
- Use of analytics with anonymization options
Analytics & Tracking
Advertising & Marketing
Website Quality Assessment
Key Observations
Website is fully accessible with no blocking or WAF challenges.
Get this report delivered to your inbox
Receive a summary of the angelinipharma.de security findings by email. Quick and easy to share with decision makers.
🛡️Security Headers
HTTP security headers analysis and recommendations.
Security Headers
HTTP security headers analysis
Weak Referrer-Policy configuration
LOWCurrent value: "no-referrer-when-downgrade"
Sensitive data may be cached
LOWCache-Control header should include "no-store" for sensitive pages
👤GDPR Compliance
Privacy and data protection assessment under GDPR regulations.
GDPR Compliance
Privacy and data protection assessment
No Cookie Consent Banner found
HIGHGDPR requires explicit consent for non-essential cookies
No Data Protection Officer mentioned
LOWLarge organizations may need to designate a DPO under GDPR
Privacy policy may not be GDPR compliant
MEDIUMPrivacy policy lacks explicit GDPR compliance elements
GDPR Compliance Analysis
🛡️NIS2 Compliance
Network & Information Security Directive compliance assessment.
NIS2 Compliance
Network & Information Security Directive
No information security framework found
HIGHNIS2 requires documented cybersecurity and information security measures
No vulnerability disclosure policy
MEDIUMNIS2 encourages coordinated vulnerability disclosure
No security policy documentation found
HIGHNIS2 requires documented cybersecurity governance and risk management
No incident response procedures found
HIGHNIS2 requires documented incident response and business continuity plans
No business continuity planning found
MEDIUMNIS2 emphasizes operational resilience and business continuity
No security contact information
HIGHNIS2 requires clear incident reporting channels
No vulnerability reporting mechanism
MEDIUMClear vulnerability reporting supports coordinated disclosure
No NIS2 reference found
LOWConsider explicitly mentioning NIS2 compliance efforts
Critical sector without clear security compliance
HIGHDetected sectors: energy, transport, banking, health, digital
Need this report as a PDF?
Download the complete angelinipharma.de security analysis as a professional PDF. Share it with your team, clients, or stakeholders.
📧Email Security
SPF, DKIM, and DMARC validation and email security assessment.
Email Security
SPF, DKIM, and DMARC validation
No SPF record found
HIGHSPF helps prevent email spoofing
No DMARC record found
HIGHDMARC provides email authentication and reporting
No DKIM record found
MEDIUMDKIM adds cryptographic signatures to emails
DMARC Details
MTA-STS Details
🏆SSL/TLS Security
Certificate validity and encryption analysis.
SSL/TLS Security
Certificate validity and encryption analysis
Unable to retrieve SSL certificate
CRITICALCould not establish secure connection to retrieve certificate information
OCSP Status
📊DNS Health
DNS configuration and security assessment.
DNS Health
DNS configuration and security assessment
DNSSEC Not Enabled
MEDIUMDNSSEC is not configured for this domain
CAA Records Not Configured
LOWCertificate Authority Authorization (CAA) records not found
Domain Transfer Lock Not Enabled
MEDIUMDomain can be transferred without authorization
Domain Delete Lock Not Enabled
LOWDomain can be deleted without additional verification
Domain Registration Details
- •No domain protection locks enabled
DNS Records
DNSSEC Status
DNS Performance
⚡Network Security
Port scanning and network exposure analysis.
Network Security
Port scanning and network exposure analysis
Good Network Security Posture
LOWNo unnecessary services detected on common risky ports
How does angelinipharma.de compare?
See how angelinipharma.de stacks up against similar websites in the same industry.
🔧Technical Analysis
Detailed technical findings and analysis from AI assessment.
Technical Analysis
Comprehensive security assessment findings
Additional Findings
Download the angelinipharma.de report as PDF
Get the complete analysis in a shareable PDF format, delivered instantly to your email with lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
Scan your own website
Liked the angelinipharma.de report? Run the same comprehensive security analysis on your domain — free, instant, and no sign-up required.
Or browse our directory of >10,000 scanned websites.
How did we do?
Your feedback directly shapes our roadmap. Rate the quality of this report, leave an optional comment, and let us know if you want our security specialists to follow up.
What others say about angelinipharma.de
Share your experience to help others make informed decisions. We verify every review by email and publish it once our moderation team approves it.
Community rating
—out of 5
0 reviews published